Acoustic MedSystems, Inc.
- Industry
- Medical Devices & Equipment
- Founded Year
- 1996
- Headquarters
- 208 Burwash Ave, Savoy, Illinois, 61874, United States
- Employee Count
- 8
Key People
- Everette C. Burdette - Chairman of the Board
-
E. Clif Burdette, PhD - CEO
Email: clifb@acousticmed.com
- Jane Smoes - Manufacturing Engineer
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team has over a decade of experience in the medical device industry.
The leadership's long-standing experience in medical devices suggests a strong foundation for the company's operations and strategic direction.
- Clinical Need
-
Aspect: Strong
Summary: The company's products address significant clinical needs in minimally invasive cancer treatments.
By focusing on minimally invasive treatments for localized cancers, the company meets a pressing demand in oncology, potentially improving patient outcomes and reducing healthcare costs.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering similar ultrasound therapy solutions.
The presence of multiple competitors in the ultrasound therapy space necessitates differentiation and strategic positioning to capture and maintain market share.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing and integrating advanced ultrasound technologies presents moderate technical challenges.
While the technology is complex, the company's experience and focus on R&D suggest they are capable of overcoming these challenges to deliver effective products.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents in ultrasound therapy technologies.
Robust intellectual property protection can deter competitors and establish the company as a leader in the field, facilitating partnerships and market entry.
- Financing
-
Aspect: SBIR/SEED
Summary: The company has secured funding through SBIR grants and private capital.
Funding from reputable sources like the NIH and NSF not only provides financial resources but also validates the company's research and development efforts.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products have received FDA 510(k) clearance for clinical use.
Achieving regulatory approval is a significant milestone that enables the company to market its products in the U.S., building credibility and trust among healthcare providers.
Opportunity Rollup
- Odds of Success
- 3.8
- Peak Market Share
- 5.45
- Segment CAGR
- 10.7%
- Market Segment
- Medical Devices & Equipment
- Market Sub Segment
- Ultrasound Therapy Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.27 |
| 2 | 0.82 |
| 3 | 1.91 |
| 4 | 3.82 |
| 5 | 5.45 |
Key Takeaway
Acoustic MedSystems is well-positioned in the growing ultrasound therapy market, leveraging strong patents and experienced leadership to address significant clinical needs.